SMARCA2 (BRM) degraders promotes differentiation and inhibit proliferation in AML models

被引：0
|
作者：
Agarwal, Anjana
Osinubi, Olusola Peace
Vykuntam, Komali
Fultang, Norman
Bhagwat, Neha
Heiser, Diane
Vaddi, Kris
Ito, Koichi
Scherle, Peggy
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1594
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of a potent, orally-available SMARCA2/4 inhibitor with in vitro and in vivo activity in preclinical models of SMARCA4-mutant NSCLC
    Drew, Allison E.
    Jacques, Suzanne L.
    Eichinger, Lindsey W.
    Pantano, Chloe
    Motwani, Vinny
    Tang, Cuyue
    Farrow, Neil
    Brach, Dorothy
    Howe, Selene
    Raimondi, Alejandra
    Dransfield, Daniel T.
    Duncan, Kenneth W.
    Stickland, Kim
    Huang, Liyue
    Lampe, John
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies
    DiNardo, Courtney D.
    Savona, Michael R.
    Kishtagari, Ashwin
    Fathi, Amir T.
    Bhalla, Kapil N.
    Agresta, Samuel
    Reilly, Sarah
    Almon, Caroline
    Hentemann, Murphy
    Hickman, Denice
    Corrigan, Dillon
    Macaraeg, Meghan
    Piel, Jessica
    Horrigan, Kim
    Nabhan, Salah
    Martin, Paul
    Stein, Eytan M.
    BLOOD, 2023, 142
  • [43] Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma
    Schallenberg, Simon
    Bork, Julian
    Essakly, Ahlem
    Alakus, Hakan
    Buettner, Reinhard
    Hillmer, Axel M.
    Bruns, Christiane
    Schroeder, Wolfgang
    Zander, Thomas
    Loeser, Heike
    Gebauer, Florian
    Quaas, Alexander
    BMC CANCER, 2020, 20 (01)
  • [44] Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma
    Simon Schallenberg
    Julian Bork
    Ahlem Essakly
    Hakan Alakus
    Reinhard Buettner
    Axel M. Hillmer
    Christiane Bruns
    Wolfgang Schroeder
    Thomas Zander
    Heike Loeser
    Florian Gebauer
    Alexander Quaas
    BMC Cancer, 20
  • [45] THE INVITRO RESPONSE OF CD2+ AML TO PROLIFERATION AND DIFFERENTIATION INDUCING AGENTS
    TRAWEEK, ST
    BENEZRA, J
    WINBERG, CD
    BRAZIEL, RM
    LABORATORY INVESTIGATION, 1989, 60 (01) : A97 - A97
  • [46] Pharmacodynamics and antitumor mechanism of the BRG1/BRM (SMARCA4/2) inhibitor FHD-286 in a Phase 1 study in subjects with AML or MDS
    Collins, Mike
    Thomsen, Astrid
    Elliott, GiNell
    Wan, Jessica
    Horrigan, Kim
    Delestre, Laure
    Penard-Lacronique, Virginie
    De Botton, Stephane
    Fiskus, Warren
    Bhalla, Kapil N.
    DiNardo, Courtney
    Agresta, Samuel
    Piel, Jessica
    Hentemann, Martin
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [47] Salidroside promotes osteoblast proliferation and differentiation via the activation of AMPK to inhibit bone resorption of knee osteoarthritis mice
    Fu, Shengqiang
    Yan, Mengjun
    Fan, Qiaoyun
    Xu, Juntao
    TISSUE & CELL, 2022, 79
  • [48] Suppressing Pitx2 inhibits proliferation and promotes differentiation of iHepSCs
    Chen, Fei
    Yao, Hao
    Wang, Minjun
    Yu, Bing
    Liu, Qinggui
    Li, Jianxiu
    He, Zhiying
    Hu, Yi-Ping
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 80 : 154 - 162
  • [49] Ablation of KDM2A Inhibits Preadipocyte Proliferation and Promotes Adipogenic Differentiation
    Hua, Yonglin
    Yue, Yongqi
    Zhao, Dan
    Ma, Yan
    Xiong, Yan
    Xiong, Xianrong
    Li, Jian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [50] FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation
    Sung, Pamela J.
    Sidoli, Simone
    Riedel, Simone S.
    Kulej, Katarzyna
    Xie, Hongbo
    Manning, Bryan
    Tsai, Daniel
    Wertheim, Gerald
    Garcia, Benjamin A.
    Meyer, Sara E.
    Bernt, Kathrin M.
    Carroll, Martin P.
    BLOOD, 2021, 138
12345